MiR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma

Alexander Swarbrick*, Susan L. Woods, Alexander Shaw, Asha Balakrishnan, Yuwei Phua, Akira Nguyen, Yvan Chanthery, Lionel Lim, Lesley J. Ashton, Robert L. Judson, Noelle Huskey, Robert Blelloch, Michelle Haber, Murray D. Norris, Peter Lengyel, Christopher S. Hackett, Thomas Preiss, Albert Chetcuti, Christopher S. Sullivan, Eric G. MarcussonWilliam Weiss, Noelle L'Etoile, Andrei Goga

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

174 Citations (Scopus)

Abstract

A drawback of electrical stimulation for muscle control is that large, fatigable motor units are preferentially recruited before smaller motor units by the lowest-intensity electrical cuff stimulation. This phenomenon limits therapeutic applications because it is precisely the opposite of the normal physiological (orderly) recruitment pattern; therefore, a mechanism to achieve orderly recruitment has been a long-sought goal in physiology, medicine and engineering. Here we demonstrate a technology for reliable orderly recruitment in vivo. We find that under optical control with microbial opsins, recruitment of motor units proceeds in the physiological recruitment sequence, as indicated by multiple independent measures of motor unit recruitment including conduction latency, contraction and relaxation times, stimulation threshold and fatigue. As a result, we observed enhanced performance and reduced fatigue in vivo. These findings point to an unanticipated new modality of neural control with broad implications for nervous system and neuromuscular physiology, disease research and therapeutic innovation.

Original languageEnglish
Pages (from-to)1134-1140
Number of pages7
JournalNature Medicine
Volume16
Issue number10
DOIs
Publication statusPublished - Oct 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'MiR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma'. Together they form a unique fingerprint.

Cite this